Bioscience Animal Health PCL (BKK:BIS)

BKK:BIS Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,281	2,324	2,412	2,194	1,975	1,760
Other Revenue	50.82	50.82	14.52	18.86	11.48	21.51
Revenue	2,332	2,374	2,427	2,213	1,986	1,782
Revenue Growth (YoY)	-6.27%	-2.16%	9.65%	11.43%	11.47%	-5.26%
Cost of Revenue	1,922	1,978	2,080	1,877	1,628	1,442
Gross Profit	409.69	396.56	347.32	335.81	358.34	340.19
Selling, General & Admin	296.18	291.02	279.03	260.17	262.37	251.89
Other Operating Expenses	8.69	10.71	-	-	-	-
Operating Expenses	304.87	301.72	279.03	260.17	262.37	261.71
Operating Income	104.82	94.84	68.29	75.63	95.97	78.47
Interest Expense	-2.34	-2.63	-1.89	-6.27	-9.94	-9.07
Interest & Investment Income	-	-	-	-	-	1.16
Earnings From Equity Investments	-	-	-	-	0.3	3.37
Currency Exchange Gain (Loss)	-	-	-	-	-	0.7
EBT Excluding Unusual Items	102.48	92.21	66.4	69.37	86.33	74.63
Gain (Loss) on Sale of Investments	-	-	-	-	0.27	-1.49
Gain (Loss) on Sale of Assets	-	-	-	6.4	-	-
Pretax Income	102.48	92.21	66.4	75.77	86.6	73.14
Income Tax Expense	23.05	20.55	13.52	16.09	17.97	18.7
Earnings From Continuing Operations	79.44	71.66	52.88	59.67	68.62	54.45
Minority Interest in Earnings	-6.81	-6.62	-2.18	-3.76	3.78	7.79
Net Income	72.63	65.04	50.71	55.92	72.4	62.23
Net Income to Common	72.63	65.04	50.71	55.92	72.4	62.23
Net Income Growth	17.24%	28.27%	-9.32%	-22.77%	16.34%	110.70%
Shares Outstanding (Basic)	314	314	314	284	220	176
Shares Outstanding (Diluted)	314	314	314	284	220	176
Shares Change (YoY)	-	-	10.71%	28.91%	25.24%	9.79%
EPS (Basic)	0.23	0.21	0.16	0.20	0.33	0.35
EPS (Diluted)	0.23	0.21	0.16	0.20	0.33	0.35
EPS Growth	17.24%	28.27%	-18.09%	-40.09%	-7.11%	91.92%
Free Cash Flow	243.09	98.5	-28.66	-47.25	18.49	-1.86
Free Cash Flow Per Share	0.77	0.31	-0.09	-0.17	0.08	-0.01
Dividend Per Share	0.170	0.140	0.110	0.122	0.410	0.138
Dividend Growth	41.67%	27.27%	-10.20%	-70.12%	198.18%	-78.28%
Gross Margin	17.57%	16.70%	14.31%	15.17%	18.04%	19.09%
Operating Margin	4.50%	3.99%	2.81%	3.42%	4.83%	4.40%
Profit Margin	3.12%	2.74%	2.09%	2.53%	3.65%	3.49%
Free Cash Flow Margin	10.43%	4.15%	-1.18%	-2.14%	0.93%	-0.10%
EBITDA	119.63	107.79	80.56	87.92	108.41	90.45
EBITDA Margin	5.13%	4.54%	3.32%	3.97%	5.46%	5.08%
D&A For EBITDA	14.81	12.95	12.27	12.29	12.44	11.98
EBIT	104.82	94.84	68.29	75.63	95.97	78.47
EBIT Margin	4.50%	3.99%	2.81%	3.42%	4.83%	4.40%
Effective Tax Rate	22.49%	22.29%	20.36%	21.24%	20.75%	25.56%
Revenue as Reported	2,340	2,374	2,427	2,220	1,987	1,784

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.